Posted in | News | Business

Air Liquide Invest in New Production Capacity in India

The Indian economy is currently creating green shoots of recovery in most business segments. This vitality is reflected in strong GDP growth in Q3 2009 (+7.9%) versus a year earlier, and even stronger growth in industrial production (+ 9.2%). This sustained manufacturing growth, plus rising automobile sales and growth in the steel industry, driven largely by domestic needs, is boosting demand for industrial gases.

Against this backdrop, Air Liquide is investing €30 million in significant new production capacity of around 540 tonnes per day of liquefied gases (oxygen, nitrogen and argon) in North & West India. In Panipat, North India, the production of liquid gases will be increased by 400 tonnes per day. In Jhagadia (Gujarat), West India, the production capacity of liquid gases will be increased by 140 tonnes per day.

Air Liquide is developing its production capacities in India to meet its customers' rising demand in growth areas. It will gain a leading position in the North and the West of India, two regions experiencing strong growth in the steel, automotive and pharmaceutical markets.

Air Liquide is also investing €6 million in a new facility near Chennai (South India) through Cryolor, its subsidiary. The new plant will produce cryogenic storage tanks starting this year (2010). It will address the requirements of the growing market for cryogenic storage products in India and neighboring markets.

Jean-Marc de Royere, Senior Vice-President Asia-Pacific, declared: "With five production sites covering the main industrial basins in the North and the West of the country, the Group will be able to better serve its Indian customers. Air Liquide offers India a unique combination of technologies and services for both the industrial and medical worlds. Emerging economies in Asia are a growth driver for the Group."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.